YouTube changes misleading abortion warning after AGs issue demand letter wnd.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wnd.com Daily Mail and Mail on Sunday newspapers.
Chris Adkins is worried. The Georgia pharmaceutical sciences professor who sparked an investigation into scientific studies that led to recent news-making retractions is worried about the “appropriate legal action” researchers have vaguely told media outlets they’re pursuing. But even more than being sued, Adkins is worried it might be too late to correct the scientific […] The post Retracted studies the latest in a decadeslong abortion-science fight appeared first on Idaho Capital Sun.
Chris Adkins is worried. The Georgia pharmaceutical sciences professor who sparked an investigation into scientific studies that led to recent news-making retractions is worried about the “appropriate legal action” researchers have vaguely told media outlets they’re pursuing. But even more than being sued, Adkins is worried it might be too late to correct the scientific […] The post Retracted studies the latest in a decadeslong abortion-science fight appeared first on Arizona Mirror.
Soumyabrata Roy/NurPhoto via Getty Images(WASHINGTON) Two of the studies cited in a ruling that suspended federal approval of the abortion pill mifepristone were retracted by a medical journal earlier this week.
Sage Publishing said it issued the retractions from the journal Health Services Research and Managerial Epidemiology because of methodology issues and conflicts of interest. The Supreme Court is hearing oral arguments in March on the case about access to mifepristone, the drug used in medication abortions which cited the studies.
Medicated abortions account for about half of all abortions, according to according to Guttmacher Institute, an organization committed to advancing reproductive rights.
U.S. District Judge Matthew Kacsmaryk cited these now-retracted studies in his decision to suspend the Food and Drug Administration s authorization of mifepristone. A federal appeals court overturned parts of the ruling, only keeping restrictions that prohibit patients from